Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
COOPER IAN (GB)
LYONS AMANDA (GB)
ORR DAVID (GB)
KIRKHAM JAMES (GB)
BLADES KEVIN (GB)
- Priority:2016/02/08
- Grant:2019/11/26
COOPER IAN (GB)
LYONS AMANDA (GB)
ORR DAVID (GB)
KIRKHAM JAMES (GB)
BLADES KEVIN (GB)
A61K31/428 (inventive)
A61K31/5415 (inventive)
A61K31/423 (inventive, first)
A61P31/04 (inventive)
A61K31/536 (inventive)
C07D263/58 (inventive)
C07D519/00 (inventive)
C07D498/04 (inventive)
A61K31/5383 (inventive)
C07D519/00 (inventive, first)
A61P31/04 (inventive)
A61K31/423 (inventive)
C07D498/04 (inventive)
C07D263/58 (inventive, first)
A61P31/06 (inventive)
A61K31/5383 (inventive)
Y02A50/30
- US-2007037781-A1 (SEA)
- WO-2008126024-A2 (APP)
- WO-2008126034-A2 (APP)
- WO-2009104159-A1 (APP)
- WO-2013021363-A1 (APP)
- WO-2013068948-A1 (APP)
- WO-2013080156-A1 (APP)
- Hameed et al., "Novel N-Linked Aminipiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy Against Mycobacterium Tuberculosis," Journal of Medicinal Chemistry, 57(11):4889-4905 (2014). (APP)
- International Search Report and Written Opinion for International Application No. PCT/GB2017/050318 dated May 9, 2017. (APP,APP)
- Reck et al., "Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity," Journal of Medicinal Chemistry, 54(22):7834-7847 (2011). (APP)
- Google PatentsLICENSE"Google Patents Research Data" by Google, based on data provided by IFI CLAIMS Patent Services and OntoChem, is licensed under a Creative Commons Attribution 4.0 International License.https://creativecommons.org/licenses/by/4.0/legalcode
- PubChem